Press Releases :: VolitionRx Ltd (VNRX)

Jul 27, 2016 7:00 am EDT

VolitionRx Granted Fourth U.S. Patent

Jun 24, 2016 7:00 am EDT

VolitionRx Appoints Dr. Edward Futcher to Board of Directors

Jun 14, 2016 7:02 am EDT

VolitionRx Publishes Study Confirming Stability of Circulating Cell-Free Nucleosomes as Biomarkers for Cancer Diagnostic Blood Tests

May 31, 2016 9:16 am EDT

VolitionRx to Present at Two Upcoming Conferences in June

May 19, 2016 7:00 am EDT

VolitionRx to Present Data Demonstrating Accuracy of NuQ® Blood Test in Detecting Colorectal Cancer at World Endoscopy Organization (WEO) Meeting

May 13, 2016 7:00 am EDT

VolitionRx Announces First Quarter 2016 Financial Results and Business Update

May 12, 2016 7:00 am EDT

VolitionRx Initiates Clinical Trial with German Cancer Research Center (DKFZ) to Evaluate NuQ(R) Blood Test for Pancreatic Cancer

May 9, 2016 7:00 am EDT

VolitionRx Schedules First Quarter 2016 Earnings Conference Call and Business Update for Friday, May 13, 2016 at 8:30am ET

Apr 20, 2016 9:00 am EDT

VolitionRx Announces Study Results Showing NuQ® Blood Test Detects Prostate Cancer Early with Significantly Higher Accuracy than PSA Test

Apr 14, 2016 7:00 am EDT

VolitionRx Appoints Louise Day as Chief Marketing and Communications Officer

rss_feed News RSS